These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22398967)

  • 21. Plasma quantitation of warfarin and warfarin alcohol by gas chromatography chemical ionization mass spectrometry in patients on warfarin maintenance therapy.
    Duffield AM; Duffield PH; Birkett DJ; Kennedy M; Wade DN
    Biomed Mass Spectrom; 1979 May; 6(5):208-11. PubMed ID: 476284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a chiral micellar electrokinetic chromatography-tandem mass spectrometry assay for simultaneous analysis of warfarin and hydroxywarfarin metabolites: application to the analysis of patients serum samples.
    Wang X; Hou J; Jann M; Hon YY; Shamsi SA
    J Chromatogr A; 2013 Jan; 1271(1):207-16. PubMed ID: 23246089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of the Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Warfarin in Plasma Using Ultra-Performance Liquid Chromatography with Tandem Mass Spectrometry (UPLC-MS/MS).
    Noguez JH; Ritchie JC
    Methods Mol Biol; 2016; 1383():21-7. PubMed ID: 26660170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans.
    O'Reilly RA; Trager WF; Rettie AE; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):290-4. PubMed ID: 3621782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of the amiodarone-warfarin interaction during long-term follow-up.
    Lu Y; Won KA; Nelson BJ; Qi D; Rausch DJ; Asinger RW
    Am J Health Syst Pharm; 2008 May; 65(10):947-52. PubMed ID: 18463344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-performance liquid chromatographic isolation and fast atom bombardment mass spectrometric identification of Di-N-desethylamiodarone, a new metabolite of amiodarone in the dog.
    Latini R; Reginato R; Burlingame AL; Kates RE
    Biomed Mass Spectrom; 1984 Sep; 11(9):466-71. PubMed ID: 6509156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of warfarin utilization in hospitalized patients: analysis of possible drug interactions.
    Guidoni CM; Camargo HP; Obreli-Neto PR; Girotto E; Pereira LR
    Int J Clin Pharm; 2016 Oct; 38(5):1048-51. PubMed ID: 27365092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of free concentrations of highly protein-bound warfarin in plasma by ultra performance liquid chromatography-tandem mass spectrometry and its correlation with the international normalized ratio.
    Huang C; Yang J; Du Y; Miao L
    Clin Chim Acta; 2008 Jul; 393(2):85-9. PubMed ID: 18406352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A liquid chromatography-electrospray tandem mass spectrometry method for the determination of antiarrhythmic drugs and their metabolites in forensic whole blood samples.
    Sørensen LK
    J Anal Toxicol; 2012 Mar; 36(2):116-22. PubMed ID: 22337781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous measurement of S-warfarin, R-warfarin, S-7-hydroxywarfarin and R-7-hydroxywarfarin in human plasma by liquid chromatography-tandem mass spectrometry.
    Zuo Z; Wo SK; Lo CM; Zhou L; Cheng G; You JH
    J Pharm Biomed Anal; 2010 Jun; 52(2):305-10. PubMed ID: 20133101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and measurement of desethylamiodarone in blood plasma specimens from amiodarone-treated patients.
    Flanagan RJ; Storey GC; Holt DW; Farmer PB
    J Pharm Pharmacol; 1982 Oct; 34(10):638-43. PubMed ID: 6128385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative liquid chromatography/mass spectrometry/mass spectrometry warfarin assay for in vitro cytochrome P450 studies.
    Zhang ZY; King BM; Wong YN
    Anal Biochem; 2001 Nov; 298(1):40-9. PubMed ID: 11673893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of Flecainide, Mexiletine, Propafenone, and Amiodarone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Slawson MH; Johnson-Davis KL
    Methods Mol Biol; 2016; 1383():11-9. PubMed ID: 26660169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous determination of dronedarone and its active metabolite debutyldronedarone in human plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
    Xie C; Yang S; Zhong D; Dai X; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(28):3071-5. PubMed ID: 21937291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of electrochemically generated iodine-containing metabolites using inductively coupled plasma mass spectrometry.
    Lohmann W; Meermann B; Möller I; Scheffer A; Karst U
    Anal Chem; 2008 Dec; 80(24):9769-75. PubMed ID: 19072274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Lee CA; Jones JP; Katayama J; Kaspera R; Jiang Y; Freiwald S; Smith E; Walker GS; Totah RA
    Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone.
    Takahashi H; Sato T; Shimoyama Y; Shioda N; Shimizu T; Kubo S; Tamura N; Tainaka H; Yasumori T; Echizen H
    Clin Pharmacol Ther; 1999 Dec; 66(6):569-81. PubMed ID: 10613612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative bioavailability study with two amiodarone tablet formulations administered with and without food in healthy subjects.
    dos Santos Filho HO; Ilha JO; Silva LC; Borges A; Mendes GD; De Nucci G
    Arzneimittelforschung; 2007; 57(9):582-90. PubMed ID: 17966757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature.
    Tomisti L; Del Re M; Bartalena L; Tanda ML; Pucci A; Pambianco F; Danesi R; Braverman LE; Martino E; Bogazzi F
    Endocr Pract; 2013; 19(6):1043-9. PubMed ID: 23807523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.